Macadildig, Vicente S.
HRN: 12-59-45 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/29/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/29/2022
09/05/2022
IV
4.5gms
Q6
Empirical Escalation
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes